IL115479A - Composition comprising diclofenac potassium for ophthalmic use - Google Patents

Composition comprising diclofenac potassium for ophthalmic use

Info

Publication number
IL115479A
IL115479A IL11547995A IL11547995A IL115479A IL 115479 A IL115479 A IL 115479A IL 11547995 A IL11547995 A IL 11547995A IL 11547995 A IL11547995 A IL 11547995A IL 115479 A IL115479 A IL 115479A
Authority
IL
Israel
Prior art keywords
composition
ophthalmic use
diclofenac potassium
diclofenac
potassium
Prior art date
Application number
IL11547995A
Other languages
English (en)
Other versions
IL115479A0 (en
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IL115479A0 publication Critical patent/IL115479A0/xx
Publication of IL115479A publication Critical patent/IL115479A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL11547995A 1994-10-10 1995-10-02 Composition comprising diclofenac potassium for ophthalmic use IL115479A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94810589 1994-10-10
EP95810574 1995-09-18

Publications (2)

Publication Number Publication Date
IL115479A0 IL115479A0 (en) 1996-01-19
IL115479A true IL115479A (en) 2000-10-31

Family

ID=26137669

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11547995A IL115479A (en) 1994-10-10 1995-10-02 Composition comprising diclofenac potassium for ophthalmic use

Country Status (6)

Country Link
US (2) US5891913A (xx)
EP (1) EP0785780A1 (xx)
AU (1) AU3609795A (xx)
CA (1) CA2201134A1 (xx)
IL (1) IL115479A (xx)
WO (1) WO1996011003A1 (xx)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6066671A (en) * 1997-12-19 2000-05-23 Alcon Laboratories, Inc. Treatment of GLC1A glaucoma with 3-benzoyl-phenylacetic acids, esters, or amides
US6646001B2 (en) 1997-12-19 2003-11-11 Alcon Manufacturing, Ltd. Use of non-steroidal anti-inflammatory agents in combination with prostaglandin FP receptor agonists to treat glaucoma and ocular hypertension
US20040152664A1 (en) * 1998-09-02 2004-08-05 Allergan, Inc. Prednisolone compositions
US20020198174A1 (en) * 2001-05-07 2002-12-26 Allergan Sales, Inc. Disinfecting and solubilizing steroid compositions
US6462071B1 (en) 2000-03-02 2002-10-08 Vitreo-Retinal Technologies, Inc. Agents for intravitreal administration to treat or prevent disorders of the eye
WO2000051620A1 (en) * 1999-03-02 2000-09-08 Vitreo-Retinal Technologies, Inc. Agents for intravitreal administration to treat or prevent disorders of the eye
US7008960B1 (en) 1999-03-02 2006-03-07 Vitreo-Retinal Technologies, Inc. Agents for intravitreal administration to treat or prevent disorders of the eye
US20020082288A1 (en) * 1999-09-16 2002-06-27 Gerald Horn Ophthalmic formulations comprising an imidazoline
WO2001019364A1 (en) 1999-09-16 2001-03-22 Horn Gerald D A method for optimizing pupil size using alpha antagonist
US8889112B2 (en) * 1999-09-16 2014-11-18 Ocularis Pharma, Llc Ophthalmic formulations including selective alpha 1 antagonists
US6420407B1 (en) 1999-09-16 2002-07-16 Gerald Horn Ophthalmic formulation which modulates dilation
US6730065B1 (en) * 2000-09-15 2004-05-04 Ocularis Pharma, Inc. Night vision composition
US7678836B2 (en) * 1999-11-04 2010-03-16 Fxs Ventures, Llc Method for rendering a contact lens wettable
US7977385B2 (en) * 2000-03-02 2011-07-12 Numoda Biotechnologies, Inc. Agents for corneal or intrastromal administration to treat or prevent disorders of the eye
US20030199574A1 (en) * 2000-03-02 2003-10-23 Vitreo-Retinal Technologies, Inc. Treatment of ophthalmic disorders using urea and urea derivatives
US6716970B2 (en) * 2000-04-21 2004-04-06 Adjuvant Pharmaceuticals, Llc Water soluble, randomly substituted partial N-partial O-acetylated chitosan, preserving compositions containing chitosan, and processes for making thereof
US20060211753A1 (en) * 2000-11-03 2006-09-21 Ocularis Pharma, Inc. Method and composition which reduces stimulation of muscles which dilate the eye
US20070110782A1 (en) * 2000-11-08 2007-05-17 Fxs Ventures, Llc L-histidine in ophthalmic solutions
PE20030828A1 (es) * 2002-03-04 2003-11-04 Novartis Ag Composicion oftalmica que comprende ascomicina
AU2003276957A1 (en) * 2002-06-13 2003-12-31 Novartis Ag Quaternised ammonium cyclodextrin compounds
CA2492989C (en) * 2002-07-23 2012-11-20 Novartis Ag Ophthalmic ointment composition comprising a drug, an ointment base and a solubilizing/dispersing agent
US20050137124A1 (en) * 2002-08-09 2005-06-23 Vitreo-Retinal Technologies, Inc. A California Corporation Agents for intravitreal administration to treat or prevent disorders of the eye
US7795203B2 (en) * 2002-09-30 2010-09-14 Babizhayev Mark A Method for topical treatment of eye disease and composition and device for said treatment
AU2003303191A1 (en) * 2002-12-20 2004-07-14 Deepak Bahri Composition comprising diclofenac for treating otic pain and inflammation
DE602004013420T2 (de) 2003-01-21 2009-06-04 Senju Pharmaceutical Co., Ltd. Wässrige flüssige zubereitung mit 2-amino-3-(4-bromobenzoyl)phenylessigsäure
US6933289B2 (en) 2003-07-01 2005-08-23 Allergan, Inc. Inhibition of irritating side effects associated with use of a topical ophthalmic medication
US20050009790A1 (en) * 2003-07-08 2005-01-13 Laszlo Sichtnik Ear and wound treatment
US7125967B2 (en) * 2003-10-08 2006-10-24 Adjuvant Pharmaceuticals, Llc Water-soluble chitosan having low endotoxin concentration and methods for making and using the same
KR20070028331A (ko) * 2004-03-10 2007-03-12 쉬모다 바이오테크(피티와이) 리미티드 안정된 주사용 디클로페낙 조성물
PE20060484A1 (es) * 2004-07-14 2006-07-06 Ucb Farchim Sa Preparaciones farmaceuticas liquidas que comprenden un compuesto de benzhidril piperizina
EA200800949A1 (ru) * 2005-09-26 2008-08-29 ПЬЕДМОН ФАРМАСЬЮТИКАЛЗ ЭлЭлСи Способы лечения и профилактики среднего отита посредством химических веществ, способствующих проникновению, для обеспечения трансмембранного поступления лекарственного средства в среднее ухо
WO2007112274A2 (en) * 2006-03-28 2007-10-04 Javelin Pharmaceuticals, Inc. Formulations of low dose non-steroidal anti-inflammatory drugs and beta-cyclodextrin
KR20170123724A (ko) * 2006-03-28 2017-11-08 자블린 파머슈티칼스 인코포레이티드 저 투여량의 디클로페낙 및 베타-사이클로덱스트린 제형
US20070238789A1 (en) * 2006-03-31 2007-10-11 Chin-Ming Chang Prednisolone acetate compositions
JP5340149B2 (ja) * 2007-06-26 2013-11-13 わかもと製薬株式会社 水性組成物
UA111147C2 (uk) * 2009-11-11 2016-04-11 Байєр Б.В. Способи та композиції для лікування або профілактики зовнішнього отиту
AU2014212274A1 (en) 2013-02-01 2015-08-13 Ocularis Pharma, Llc Aqueous ophthalmic solutions of phentolamine and medical uses thereof
DK2950800T3 (da) 2013-02-01 2020-11-16 Ocuphire Pharma Inc Fremgangsmåder og sammensætninger til daglig ophthalmisk administration af phentolamin til forbedring af synsevnen
HUE042528T2 (hu) * 2013-03-14 2019-07-29 Panoptica Inc Okuláris készítmények a szem hátsó szegmenséhez történõ gyógyszer-kijuttatáshoz
KR101524473B1 (ko) * 2014-12-22 2015-06-02 주식회사 한국팜비오 주사제 조성물
CN113164452A (zh) 2018-10-26 2021-07-23 奥库菲尔制药股份有限公司 治疗老花眼、散瞳和其他眼部疾病的方法和组合物
CN115368310A (zh) 2021-05-18 2022-11-22 奥库菲尔医药公司 合成甲磺酸酚妥拉明的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH666621A5 (de) * 1986-06-27 1988-08-15 Ciba Geigy Ag Topisch applizierbare pharmazeutische zusammensetzungen mit systemischer wirkung.
US5414011A (en) * 1987-09-11 1995-05-09 Syntex (U.S.A.) Inc. Preservative system for ophthalmic formulations
NO175404C (no) * 1987-09-11 1994-10-12 Syntex Inc Fremgangsmåte for fremstilling av et öyepreparat og konserveringsmiddelsystem for et slikt preparat
US4960799A (en) * 1988-09-13 1990-10-02 Ciba-Geigy Corporation Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use
ES2079994B1 (es) * 1992-10-07 1996-08-01 Cusi Lab Formulacion farmaceutica a base de polimixina-trimetoprim y un agente antiinflamatorio para su utilizacion topica oftalmica y otica.

Also Published As

Publication number Publication date
IL115479A0 (en) 1996-01-19
CA2201134A1 (en) 1996-04-18
US5891913A (en) 1999-04-06
US6107343A (en) 2000-08-22
WO1996011003A1 (en) 1996-04-18
EP0785780A1 (en) 1997-07-30
AU3609795A (en) 1996-05-02

Similar Documents

Publication Publication Date Title
IL115479A (en) Composition comprising diclofenac potassium for ophthalmic use
ZA954573B (en) Film composition
HK1000579A1 (en) Hydrogenated rubber composition
AU2263295A (en) Contrast agents
AU6722194A (en) Novel medical use for gaba agonists
GB2305434B (en) Abrasive cleaning composition
HUT78017A (hu) Fogápoló készítmény
AU7247094A (en) Composition for cleaning contact lenses
PL319092A1 (en) Herbicidal composition
GB9511983D0 (en) Ophthalmic pharmaceutical composition
HU9603204D0 (en) Substituted 3-phenylpyrazoles for use as herbicides
SG24100A1 (en) Optically active tolane derivatives
AU2753695A (en) Herbicidal composition
ZA969798B (en) Herbicidal composition
ZA96400B (en) Herbicidal composition
AU3828595A (en) Cleaning composition
GB9412718D0 (en) Cleaning composition
LTIP1970A (en) Composition for ophthalmic use
AU4001295A (en) New cytotoxic agents
ZA954571B (en) Film composition
GB9509929D0 (en) Herbicidal composition
AU6973094A (en) Composition for ophthalmic use
ZA958488B (en) Composition for ophthalmic use
AU3190595A (en) Corneal therapeutic agent
LTIP1969A (en) Composition for ophthalmic use

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed